Treatment of chlordecone (Kepone) toxicity with cholestyramine. Results of a controlled clinical trial.
about
Possible estuary-associated syndrome: symptoms, vision, and treatmentDevelopmental effects of endocrine-disrupting chemicals in wildlife and humansSome evidence of effects of environmental chemicals on the endocrine system in childrenResidential and recreational acquisition of possible estuary-associated syndrome: a new approach to successful diagnosis and treatmentA review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxinsParallel assessment of male reproductive function in workers and wild rats exposed to pesticides in banana plantations in GuadeloupeClinical evaluation of liver structure and function in humans exposed to halogenated hydrocarbonsPossibilities of detecting health effects by studies of populations exposed to chemicals from waste disposal sitesTime to pregnancy and exposure to pesticides in Danish farmers. ASCLEPIOS Study GroupEffects of the workplace on fertility and related reproductive outcomes.Estrogenic activity of the insecticide chlordecone (Kepone) and interaction with uterine estrogen receptorsThe PBB episode in Michigan: an overall appraisal.Secular variations in sperm quality: fact or science fiction?p-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene.How work-place conditions, environmental toxicants and lifestyle affect male reproductive function.Chlordecone altered hepatic disposition of [14C]cholesterol and plasma cholesterol distribution but not SR-BI or ABCG8 proteins in livers of C57BL/6 mice.Intestinal disease and the urban environmentChlordecone exposure and adverse effects in French West Indies populations.Environmental chemicals and nervous system dysfunction.Gastrointestinal Elimination of Perfluorinated Compounds Using Cholestyramine and Chlorella pyrenoidosa.Reduction of the body burden of PCBs and DDE by dietary intervention in a randomized trial.Elimination of persistent toxicants from the human body.Especial considerations for neurotoxicological research.Kepone: a chemical disaster in Hopewell, Virginia.Therapeutic approaches for chlordecone poisoning in humans.Transfer of persistent chemicals in milk.Regulation of hepatic drug transporter activity and expression by organochlorine pesticides.Relative bioavailability of tropical volcanic soil-bound chlordecone in laying hens (Gallus domesticus).Pharmacokinetics of halogenated hydrocarbons.Perspectives on reproductive and developmental toxicity.Estrogenic activity of the insecticide chlordecone in the reproductive tract of birds and mammals.Chlordecone-induced hepatic dysfunction.Elimination of drugs by passive diffusion from blood to intestinal lumen: factors influencing nonbiliary excretion by the intestinal tract.Enhancement of xenobiotic elimination: role of intestinal excretion.Agents affecting the male reproductive system: effects of structure on activity.Metabolic disposition of antihyperlipidemic agents in man and laboratory animals.ATSDR evaluation of health effects of chemicals. II. Mirex and chlordecone: health effects, toxicokinetics, human exposure, and environmental fate.Activated carbon, a useful medium to bind chlordecone in soil and limit its transfer to growing goat kids.Human Elimination of Organochlorine Pesticides: Blood, Urine, and Sweat Study.Procedures to enhance withdrawal of xenobiotics from chickens.
P2860
Q24536805-1BD78256-9518-403F-A065-7F2CB4756D63Q24554428-8E88F075-0D7B-42E3-B00C-CCCEBC9B24E2Q24646443-C327942F-66CB-4289-9844-AF751CC62676Q24814777-8FFA30D4-8F24-4519-8AE8-083ED8AED24DQ28382991-2447DED8-39D5-4D57-904F-A6F865DA5E3AQ28385343-97664E11-B6D4-459A-A52D-FB4D3CDE2E90Q28391012-FBB4F8E7-4C71-4FE7-80DF-B0775071F616Q28391045-E14EF61D-49F3-422F-A1F5-FF7CC9811272Q28394367-B37BA40E-0686-4D29-8157-D0900C5AAD1DQ30499483-872F2527-D655-442E-9355-F75F2881BDDFQ33990696-536ED4D6-C63A-4067-AAF4-D0B37B07673FQ34161715-F5BB98A4-FC99-4446-BF7E-F8700900BDBFQ34582054-6E60AB6F-A775-4EFC-9ABA-CD06D021E8B3Q34840208-C00128D0-1B64-4E95-8B2A-19222A326AB0Q34881231-1931D295-5D7B-4588-8DD2-2C51CA1A92A9Q35129292-7616A480-4462-48E2-A71A-6E4460FDE06EQ35135304-FC6EE577-B88D-498A-B0C6-3744AAD86F97Q36460428-49DFFC5C-A5C3-463C-86EE-C1B2CA05921DQ36998787-9F558F83-632C-4838-AC8A-F82C05C81DBAQ37196919-896503AA-B355-44AF-9D1E-BE693B84CBC6Q37650319-85CE3F63-CC44-4B3D-9442-7897C17C0648Q37733171-BA734511-C9D7-422E-BF8C-B03B93F6021DQ38154051-FACCF34C-8684-4424-AF58-8AB6E9F16AA3Q38584335-EE7B7B08-6852-4AEB-9F8D-B7910A094FEBQ38584385-A734B48B-C9FD-4836-95F2-3112F2D53BA9Q38782970-5840DFB7-0A5B-4112-BEC8-DFA1D865C35CQ39030497-2D56B8F0-A26F-43D3-89AD-55C269CCA539Q39110068-7ACD295B-32E1-4726-8D22-D75BCCE53B6BQ39552873-3A850E21-F5CE-442C-A81D-F6788D50CBC3Q39657059-3E0B2941-FBE5-43A1-988B-1FF8C536D4B3Q40102977-4F013E40-1F7C-4579-8D5D-D0EC6B3DAF9CQ40102983-4AC2C9D7-C5A5-4710-A14D-86F6B4C8976EQ40177614-8E0A0DBD-3E32-4FD2-B69E-1DA3679C3EA4Q40200353-80993CCB-AA82-47F3-B2A2-F7BFD58D07BFQ40200397-925C319E-E568-471D-9CF8-0CD6B34B51B8Q40303400-3F3722A9-F3A9-45CF-B0CF-3E175A37152DQ41046093-2B679DB7-63C7-4F87-8E74-3E93EE698C60Q41058510-A9963D52-CA23-4D7F-9CFA-00AB06AF0D1CQ41496476-3E09CA10-9151-41AD-B839-3FAAFFE31638Q42205417-5F3E8903-044B-45DC-A670-33127DBDF2B0
P2860
Treatment of chlordecone (Kepone) toxicity with cholestyramine. Results of a controlled clinical trial.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Treatment of chlordecone (Kepo ...... f a controlled clinical trial.
@en
Treatment of chlordecone
@nl
type
label
Treatment of chlordecone (Kepo ...... f a controlled clinical trial.
@en
Treatment of chlordecone
@nl
prefLabel
Treatment of chlordecone (Kepo ...... f a controlled clinical trial.
@en
Treatment of chlordecone
@nl
P2093
P1476
Treatment of chlordecone (Kepo ...... f a controlled clinical trial.
@en
P2093
P304
P356
10.1056/NEJM197802022980504
P407
P577
1978-02-01T00:00:00Z